Protein engineering over the past four years has made rhodopsin-based genetically encoded voltage indicators a leading candidate to achieve the task of reporting action potentials from a population of genetically targeted neurons in vivo. Rational design and large-scale screening efforts have steadily improved the dynamic range and kinetics of the rhodopsin voltage-sensing domain, and coupling these rhodopsins to bright fluorescent proteins has supported bright fluorescence readout of the large and rapid rhodopsin voltage response. The rhodopsin-fluorescent protein fusions have the highest achieved signal-to-noise ratios for detecting action potentials in neuronal cultures to date, and have successfully reported single spike events in vivo. Given the rapid pace of current development, the genetically encoded voltage indicator class is nearing the goal of robust spike imaging during live-animal behavioral experiments. The desire for genetically encoded voltage indicators (GEVIs) that precisely read out the arbitrary spiking activity of multiple genetically targeted neurons stems from the large potential impact that these precise recordings of the spiking code can have at connecting neural activity to animal behavior [1, 2] . Although genetically encoded calcium sensors offer similar targeting capabilities and continued development of these sensors has resulted in tools that can report the broad outlines of neural activity with high fidelity [3, 4] , GEVIs have the potential to read out the spike train with millisecond temporal resolution and map membrane potential hyperpolarizations, capabilities not present with calcium sensors. Voltage sensors developed over the past two decades have demonstrated improving signal-to-noise ratio (SNR) in well controlled culture experiments, but only moderate success when measuring action potentials in live-brain imaging preparations, where noise sources such as scattering, hemodynamics, and general background fluorescence wash out the small sensor response. Here we describe the progress of rhodopsin-based voltage sensors over the past four years, both in developing rhodopsins to serve as highly effective voltage-sensing domains (VSDs), and in developing methods to extract the information from these VSDs with high SNR. Fluorescent proteinrhodopsin fusion sensors represent the leading edge of voltage imaging tools when compared to the other members of the GEVI class, and are on the cusp of reporting neural spiking activity from live animal preparations.
The desire for genetically encoded voltage indicators (GEVIs) that precisely read out the arbitrary spiking activity of multiple genetically targeted neurons stems from the large potential impact that these precise recordings of the spiking code can have at connecting neural activity to animal behavior [1, 2] . Although genetically encoded calcium sensors offer similar targeting capabilities and continued development of these sensors has resulted in tools that can report the broad outlines of neural activity with high fidelity [3, 4] , GEVIs have the potential to read out the spike train with millisecond temporal resolution and map membrane potential hyperpolarizations, capabilities not present with calcium sensors. Voltage sensors developed over the past two decades have demonstrated improving signal-to-noise ratio (SNR) in well controlled culture experiments, but only moderate success when measuring action potentials in live-brain imaging preparations, where noise sources such as scattering, hemodynamics, and general background fluorescence wash out the small sensor response. Here we describe the progress of rhodopsin-based voltage sensors over the past four years, both in developing rhodopsins to serve as highly effective voltage-sensing domains (VSDs), and in developing methods to extract the information from these VSDs with high SNR. Fluorescent proteinrhodopsin fusion sensors represent the leading edge of voltage imaging tools when compared to the other members of the GEVI class, and are on the cusp of reporting neural spiking activity from live animal preparations.
Early generations of GEVIs fused voltage-sensitive phosphatases (VSPs) such as the Ciona intestinalis voltagesensitive domain (Ci-VSD) with fluorescent proteins (FPs). In particular, the voltage sensitive fluorescent protein (VSFP) design attached pairs of FPs that interacted with fluorescence resonance energy transfer (FRET) to one Ci-VSD terminus [5] [6] [7] [8] (Figure 1a) , or split the pair between the termini [9, 10] . The fluorescence ratio of the two FPs thus reported the voltagesensitive conformation of Ci-VSD with the high brightness of FPs. However, these sensors generally had slow voltage-sensing kinetics (>20 ms) and therefore had only small optical response to neuronal action potentials in the culture setting ($1% DF/F). Subsequent engineering of the FP and VSD components resulted in sensors that reported the VSP conformation change with charge sensing FPs or allostery. In particular, Arclight (Figure 1b ) [11, 12] and ASAP1 (Figure 1c ) [13] coupled a pHluorin mutant to Ci-VSD and a circularly permuted GFP to the homologous Galos galos VSD (gg-VSD), respectively, and currently represent the best engineered VSP-based sensors in terms of dynamic range (which improves response to long voltage transients) and kinetics (which improves response to short voltage transients) ( Table 1) .
Archaerhodopsin-3 (Arch) has simultaneously risen as an alternative VSD with voltage-sensitive electronic configurations that modified the protein's absorption spectrum (Figure 1d ) [14] . The initial report of Arch voltagesensitive fluorescence suggested that rhodopsins could serve as VSDs with fast and large dynamic range voltage response. Rational design then improved Arch using sitedirected mutagenesis that drew heavily on existing literature detailing how mutations in the homologous bacteriorhodopsin might affect the rhodopsin photocycle [15,16 ,17-20] . These studies mutagenizing the charge centers of Arch within the proton conduction pathway significantly improved the kinetics and voltage sensitivity of the rhodopsin protonation event that supports voltage-sensitive absorption and fluorescence. Specifically, manipulation of the charge center D95 [21 ,22 ,23,24] eliminated the protein's native photocurrent, while manipulation of the charge center D106
Rhodopsin-based genetically encoded voltage indicators Gong 85 During voltage depolarization, rhodopsin absorption increased, and the FP fluorescence decreased. Because the FP fluorescence quantum yield was orders of magnitude higher than the rhodopsin fluorescence quantum yield, the FP channel had much higher shot-noise limited SNR than the rhodopsin channel, and optical experiments using FRET-opsin sensors imaged only the FP channel. The '+' and '-' kinetics modeled the voltage sensor's optical responses to depolarizing and hyperpolarizing voltage transients using bi-exponential fits to the experimental data, respectively. In brief, P fast is the percentage of the amplitude associated with the fast component in response to depolarizing and hyperpolarizing voltage transients, and t fast is the fast time constants of the response to depolarizing and hyperpolarizing voltage transients. NR: not reported. [21 ,22 ] increased the protein's voltage sensing kinetics. The rational designs improved the sensing dynamic range and kinetics of the Arch photocurrent-knockout mutants, but kinetics remained at $10 ms, far slower than the kinetics of neural action potentials. In addition to rational approaches, more recent large-scale screening efforts using random mutagenesis and designed spectral manipulations led to the creation of QuasAr [25 ] and Archer [26 ] , respectively. Both designs reduced voltage sensitive kinetics to <1 ms, and detected spikes with DF/F = 25-50%, while marginally increasing the sensor brightness ( Table 1) . As a trade-off for kinetics however, designs such as Archer had residual photocurrent because they did not employ the photocurrent reduction mutations in the proton conduction pathway [26 ] . In either case, the quantum yields of these sensors remained below 1%, and high fidelity experimental recordings of spikes in culture settings required 01 W mm À2 excitation intensity. The dim fluorescence of these sensors, comparable in intensity to autofluorescence from bulk tissue, led to greatly reduced DF/F values during slice imaging experiments [25 ] and present additional challenges for in vivo preparations such as phototoxicity or tissue heating.
Incidentally, FRET served as a mechanism to improve the effective quantum yields of rhodopsin VSDs while maintaining the fast, highly voltage-sensitive optical response. By fusing bright FPs, which served as the donor of the FRET pair and bright fluorescence readout, in close proximity to the rhodopsin ion channel, which served as the acceptor of the FRET pair and VSD, FP-rhodopsin sensors, or FRET-opsins, reported the voltage-sensitive rhodopsin electronic configuration and absorption with high brightness. Initial studies attaching fluorescent proteins to sensory rhodopsins [27] was able to extract the kinetics of various stages of the rhodopsin photocycle. Subsequently, two reports combined engineered rhodopsin VSDs such as the rhodopsin from L. Maculans (MacQ) [28 ] and QuasAr [29 ] with FPs in the FRET-opsin configuration. Although the Mac rhodopsin [30] originated from eukaryotes instead of archaea, its homology with Arch and bacteriorhodopsin enabled similar protein engineering to suppress the photocurrent and speed up the voltage sensing kinetics [28 ] .
Successful design of FRET sensors hinges on maximizing FRET interaction by maximizing the spectral overlap and minimizing the physical distance between the donor and acceptor components. These design parameters in FRET-opsin sensors were respectively limited by the availability of different colored FPs to couple to the rhodopsin absorption spectrum and the steric hindrance that prevents proper protein folding and membrane localization at short FP-rhodopsin distances. The FRET-opsin designs dealt with the former design parameter by using fluorescent proteins of various colors as the donor. Because the absorption spectra of Mac and QuasAr peaked similarly in the $560-580 nm range, yellow and orange FPs, such as mCitrine and mOrange2, maximized the spectral coupling and sensor DF/F [28 ,29 ] . The FRET-opsin designs dealt with the latter design parameter by modifying the linker length between the VSD and FP components. Reducing the linker length generally increased the FRET interaction and the DF/F response, but the sensor proteins failed to fold and localize to the neuron membrane at crucially short linker lengths [28 ,29 ] .
The optimal Mac and QuasAr FRET-opsin sensors produced similar kinetics of 3 ms for the fast rise component that responded to voltage depolarizations and similar dynamic ranges, and thus produced similar DF/F $ 5% in response to neuronal action potentials in culture ( Figure 2a , Table 1 ) [28 ,29 ] . Signal-to-noise ratio was defined as the ratio of the peak fluorescence transient response to the shot-noise limited baseline fluctuations, or SNR ¼ ðDF=FÞ Â ffiffiffiffi N p , with N the number of photons collected per neuron per frame. These culture experiments reached SNR ! 25. The bright fluorescence of these sensors also enabled imaging of action potentials in intact slice tissue preparations, as the fluorescent protein read-out was significantly higher (5-10Â) than the background autofluorescence, and had sufficiently low shot-noise limited background fluctuations to resolve individual action potentials from cortical pyramidal neurons with DF/F $ 2.5% and SNR > 10 ( Figure 2b ) [28 ] . When tested in live animal preparations, MacQ-mCitrine reported the long-duration dendritic action potentials from cerebellar Purkinje neurons with DF/F $ 1% and SNR $ 10 (Figure 2c) , aided by the slow kinetics of these complex spikes that matched sensor kinetics and the large membrane surface area of the Purkinje neuron dendritic tree that elevated the effective brightness of the imaged neurons [28 ] . With these favorable conditions, MacQmCitrine was able to enter the regime of single spike detection in vivo, which was previously untrodden ground for the GEVI field.
The body of work using FRET-opsin sensors above highlights the inextricable relationship between the imaged cell type or preparation and the fidelity of voltage sensors. Even in controlled culture experiments, comparison of sensor performance in reporting action potentials is often confounded by the different experimental conditions such as optical excitation power, electrophysiology holding potentials and current injection protocols, or even culture conditions that lead to varied action potential waveforms. Although benchmarking sensors directly in vivo using neurons with known physiology will be the ultimate test bed in determining sensor merit, concurrent reports of action potential shape and optical design with the corresponding SNR measures will greatly help in comparing various sensors on an equal footing.
After establishing these standards for culture-based assays, we previously described methods to compare sensor response to action potentials using both shot-noise limited SNR measures and the spike detection fidelity metric, d
0 [31 ], with both measures utilizing the experimentally measured DF/F and brightness of the sensors; whereas SNR described only the peak response of sensors relative to the shot-noise limited background, d 0 measured the spike detection fidelity by considering the full response waveform. FRET-opsin based sensors had superior brightness and DF/F response and thus led in spike detection metrics when compared to existing sensors at 15 mW mm À2 excitation intensity (Figure 3a) .
The fast imaging frame rates required for catching the fast voltage fluorescence transients necessitated large values of SNR or d 0 $ 10 to accurately classify neuron spiking, which corresponds to approximately one false positive per hour of imaging at 1 kHz frame rate while balancing the probability of false positives and false negatives. FRETopsin sensors performed over this threshold in culture and slice settings for detecting pyramidal neuron spikes (Figure 3a) . However, experiments imaging inhibitory neurons expressing the same sensors in slice failed to meet this threshold, and suggest that the imaging of similarly short action potentials of neocortical neurons in live-mice experiments, which includes additional nonstationary noise sources such as brain motion, blood flow, and enhanced scattering, is currently only on the cusp of realization. Given an estimate that sensors suffer an order of magnitude decrease in SNR when transitioning from culture experiments to live animal imaging due to these , or by the SNR metric, which was the ratio of the peak optical DF/F response to the shot-noise limited fluorescence background fluctuations. The FRET-opsin sensors are on the leading edge of sensor capabilities using either spike detection metric, and current culture and slice experiments using these sensors support high fidelity spike classification with d 0 > 10. Data reproduced from Ref. [28 ] . (b) Sensor capabilities to detect action potentials within fast spiking trains in culture settings, that is, the ratio of d 0 to the sensor response time constant (t), have increased exponentially as a function of time over the past 3 years, again with FRET-opsin sensors at the head of this development. Given the pace of sensor development, the field is quickly nearing the threshold for performing live animal spike imaging experiments.
excess noise sources and shortened action potentials, d 0 $ 100 in culture is necessary to support in vivo imaging of spikes, and current FRET-opsin sensors are still factors of $3-4 away.
The FRET-opsin sensors nevertheless typify the recent voltage sensors developments that have exponentially increased the capability to imaging spikes within fastspiking trains, represented by the ratio of d 0 to the sensor response kinetics (Figure 3b) . In order to continue the trend of increasing sensor performance, future development of FRET-opsin sensors will need to resolve how to manipulate the FRET efficiency while optimizing the (1) voltage sensitivity, (2) kinetics, and (3) spectral diversity of the sensors. First, optimized FRET sensors attain maximum sensitivity at the inflection point around $50% FRET efficiency, which translates to the FP channel having approximately half of the DF/F response of the rhodopsin channel. Current designs based on Mac and QuasAr failed to attain this FRET efficiency even at short linker lengths, suggesting that superior spectral overlap between the FP donor emission spectrum and the rhodopsin acceptor absorption spectrum could improve sensor performance. Second, we observed that the FP fluorescence channel of the FRET-opsin sensors had slower kinetics than the kinetics observed when directly imaging the weak fluorescence of the rhodopsin VSDs (Table 1 ). This suggests that the broad spectral widths of fluorescent protein emission profiles may overlap with multiple portions of the rhodopsin absorption spectrum that undergo different kinetics during voltage sensing, and that better spectral engineering may improve sensor kinetics as well. Finally, as noted with previous chronic expression of rhodopsin-red fluorescent protein fusions in live animals, we observed intracellular aggregation when the orange version of the FRET-opsin sensors was expressed in mice [28 ] , suggesting that the monomericity of some FP-rhodopsin fusions is insufficient to avoid large background. All three of these observations suggest that further development of the rhodopsin and FP components of the FRET-opsins sensors could improve their capabilities to meet the challenge of in vivo spike detection.
To conclude, the development of voltage sensors over the past few years have significantly improved the outlook on performing in vivo quantification of single spikes. The exponential growth in sensor performance must level off, due to intrinsic biophysical limitations of charge distribution between different rhodopsin electronic configurations or the physical constraints of the VSP conformation. However, due to the super-exponential reduction of spike detection error rates with increasing measures of SNR, even linear gains in sensor performance will lead to large gains in the ability to record spikes from neurons in live-animal preparations, or consequently, in the numbers of neurons simultaneously imaged. For example, a modest improvement from d 0 = 2 to d 0 = 4 decreases the spike detection error probability from $10 À1 to $10 À3 . In our current imaging regime, out-of-plane fluorescence from non-specifically labeled neuronal processes contributes large background emission that lowers the SNR. Thus, combining GEVIs with appropriate imaging modalities that provide depth sectioning and genetic labeling strategies that target ever smaller pools of neurons relevant to animal behaviors will enhance the capabilities of GEVIs as well. The current rate of sensor advancement and potential assistance from optical and genetic engineering suggest that robust live-animal voltage imaging of action potentials is nearing manifestation.
